• Careers

  • News

  • Healthcare Professionals

  • Adverse Event Reporting

  • Contact us

    • Email Us

    • Call Us

    • Privacy Policy

    • Terms &Conditions

  • Career-Seekers

  • News & Media

  • Healthcare Professionals

  • Connect With Us

  • Terms and Conditions

  • Privacy Policy

  • Adverse Event Reporting

  • Change Region

  • Site Map

india manufacturing

​​​​​​​In India, Pfizer operates three manufacturing plants and works with 18 other partner sites to produce quality medicines for patients in India. All manufacturing operations are carried out in full compliance with local laws and in line with stringent Global Pfizer Quality and environment, health and safety (EHS) standards.

Manufacturing and Distribution


3 Manufacturing sites

Producing for 50 + Countries


18 Contract manufactures

~300 SKUS



Pfizer Manufacturing Sites

I. Goa, India ​​​​​

An award-winning facility that manufactures small molecule drugs and local solids

Year of establishment: 2001

No​​​​​​​. of colleagues: ​​​​​​​~150

Capacity: ​​​​​​​​​​​​​​4 billion tablets annually

​​​​​​​Markets supplied: ​​​​​​​India, Bangladesh, Sri Lanka, Nepal

II. Visakhapatnam, India

One of Pfizer’s largest modern facilities in the world for sterile injectables​​​​​​​​​​​​

Year of establishment: ​​​​​​​2015

No​​​​​​​. of colleagues: ​​​​​​​~2000

Capacity: ​​​​​​​380 million vials annually​​​​​​

Markets supplied: ​​​​​​​United States, Canada (filings in progress)

III. Ahmedabad, India 

The Zydus Hospira Oncology Pvt. Ltd. (ZHOPL) plant is a 50:50 joint venture with Zydus Cadila that manufactures sterile injectables.

Year of establishment: 2005

No​​​​​​​. of colleagues: ​​​​​​​~150

Capacity: ​​​​​​​7 million vials annually

Markets supplied: ​​​​​​​US, Europe, Australia and New Zealand, Japan, Canada, Asia Pacific​​​​​​​

Pfizer puts a strong emphasis on conservation of resources at our manufacturing sites. Our Goa plant has received a number of awards including one for Excellence in Environment Sustainability because of its emphasis on global safety, environmental health and hygiene standards. We have also replaced several old manufacturing machines and dehumidifiers with high-efficiency machines to reduce energy consumption.
At Vishakhapatnam, our plant runs exhaustive sustainability programs on all three areas of sustainability (Water, Energy and Waste). The site has met all sustainability targets over the years and has been recognized by reputed organizations.
We conduct several training programmes through the year to motivate colleagues and encourage best practices. We arrange the Integrated Manufacturing Excellence Program (IMEx) for leaders and the Six Sigma Green Belt training and Operational Excellence trainings.
Special measures during Covid-19
During the Covid-19 pandemic, it was clear to us that we needed to ensure an uninterrupted supply of medicines without any disruption, while also taking care of the health and safety of our employees. We took all the necessary steps to make certain that there was no disruption to supply during this time and ensured that the health and safety of our employees remained a top priority. Our plants were classified as an ‘essential service’ and remained operational through the lockdowns. All colleagues maintained social distance during operations, were screened for their temperature, were provided masks and sanitization dispensers on site.Insert your text here
about usPfizer IncOur Legacy​​​​​​​Our Purpose & Values​​​​​​​Pfizer's Code of ConductPfizer in India​​​​​Our ManufacturingOur Distribution Networkour scienceFocus AreasR&D SupportClinical Trials in Indiaour peopleWorking at PfizerOur Culture & ValuesCareers at Pfizer#BeTheBreakthroughDiversity and InclusionGreat Place To Workour community effortsCSR VisionCSR IntiativeCSR Volunteeringyour healthDisease & ConditionsManaging Your HealthBiology Explained